Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 66 (92) , S2-S6
- https://doi.org/10.1111/j.1523-1755.2004.09201.x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With NephropathyCirculation, 2004
- Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAALKidney International, 2004
- Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-AnalysisAnnals of Internal Medicine, 2003
- The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL StudyKidney International, 2003
- Proteinuria and the risk of developing end-stage renal diseaseKidney International, 2003
- Proteinuria as a modifiable risk factor for the progression of non-diabetic renal diseaseKidney International, 2001
- Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?Current Opinion in Nephrology and Hypertension, 2000
- Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?Kidney International, 1990
- Predictors of Cardiovascular Morbidity in Treated Hypertension: Results from the Primary Preventive Trial in Goteborg, SwedenJournal Of Hypertension, 1985
- The prognostic significance of proteinuria: The Framingham studyAmerican Heart Journal, 1984